Kinnate Biopharma Inc.

KNTE · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$56,998$29,261$116,096$365,462
Short-Term Investments$97,036$172,214$103,362$31,398
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,143$3,637$5,639$3,343
Total Curr. Assets$158,177$230,837$258,690$400,203
Property Plant & Equip (Net)$4,760$6,448$956$368
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$10,630$39,139$105,449$0
Tax Assets$0$0$0$0
Other NC Assets$38$2,402$1,769$0
Total NC Assets$15,428$47,989$108,174$368
Other Assets$0$0$0$0
Total Assets$173,605$278,826$366,864$400,571
Liabilities
Payables$2,031$2,970$3,148$3,940
Short-Term Debt$892$991$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,072$13,206$9,239$3,364
Total Curr. Liab.$11,995$17,167$12,387$7,304
LT Debt$2,283$3,191$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$2,283$3,191$35,000$0
Other Liabilities$0$0-$35,000$0
Cap. Leases$2,283$4,182$0$0
Total Liabilities$14,278$20,358$12,387$7,304
Equity
Pref Stock$0$0$0$400,571
Common Stock$5$4$4$4
Retained Earnings-$372,012-$259,363-$143,092-$53,329
AOCI-$12-$1,410-$524-$9
Other Equity$531,346$484,237$463,089$446,601
Total Equity$159,327$223,468$319,477$393,267
Supplemental Information
Minority Interest$0$35,000$35,000$0
Total Liab. & Tot. Equity$173,605$278,826$366,864$400,571
Net Debt-$53,823-$25,079-$116,096-$365,462